EJMO Volume : 6 Issue : 2 Year : 2022

COVID-19 in EJMO 6/2EJMO Current Issue EJMO Archive EJMO & Congress of Oncology and immunotherapy association Most Cited Articles Ahead of Print Most Accessed Articles

ICMJE COI Form

EJMO Sponsors

Arven
Amgen
Astellas
Bristol-Myers Squibb
Johnson Johnson
Merck
Pfizer
Novartis
Omnigen
Mustafa Nevzat
Roche
TEVA
Trpharm

Page not found.

EJMO Citations

Number of Citations: 1804
Number of Articles: 292
Accept Ratio : 18.2 %

Days from submission to final decision 26.5

EJMO NLM ID: 101720527

Quick Search

�In authors and institutes
�In titles and abstracts
�In keywords
�In all